Still fourth down and goal in the Medtronic transfer pricing dispute
Appearing in the September 2025 issue of Insights: On September 3, 2025, the Eighth Circuit issued its long-awaited decision in Medtronic, Inc. & Consolidated Subsidiaries v. Commissioner, vacating the U.S. Tax Court’s second decision and remanding the case for further proceedings. The opinion marks a pivotal moment in the ongoing saga over transfer pricing of intangible property between Medtronic and its Puerto Rican manufacturing subsidiary (“MPROC”), and provides critical guidance on the application of the best method rule under Treas. Reg. §1.482-1(c). Still at issue The controversy remains centered on the appropriate royalty rate for MPROC’s use of intangible property, including patents, know-how, and regulatory approvals, licensed by Medtronic, Inc. Medtronic relied on the Comparable Uncontrolled Transaction (“CUT”) method, referencing a licensing agreement with Siemens Pacesetter. The IRS instead applied the Comparable Profits Method (“CPM”), arguing that MPROC’s profitability should be benchmarked against comparable manufacturers.… Read More »Still fourth down and goal in the Medtronic transfer pricing dispute